The multivariate logistic regression model that incorporated the latest available measures also showed that increased respiratory allergen-specific IgE was significantly inversely associated with glioma risk (OR for respiratory allergen-specific IgE > 0.35 PAU/L: 0.48, P = .005, Table 4). Here, IGHE is linked to glioma.